Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 27 results.
User Information
Export Records
  1. 1.   Nonhuman primate models of human viral infections
  2. Estes, Jake; Wong, Scott W.; Brenchley, Jason M.
  3. NATURE REVIEWS IMMUNOLOGY. 2018, Jun; 18(6): 390-404.
  1. 2.   KIR2DL2 Enhances Protective and Detrimental HLA Class I-Mediated Immunity in Chronic Viral Infection
  2. al Basatena, N. K. S.; MacNamara, A.; Vine, A. M.; Thio, C. L.; Astemborski, J.; Usuku, K.; Osame, M.; Kirk, G. D.; Donfield, S. M.; Goedert, J. J.; Bangham, C. R. M.; Carrington, M.; Khakoo, S. I.; Asquith, B.
  3. Plos Pathogens. 2011, Oct; 7(10): 12.
  1. 3.   In Vivo Consequences of Liver-Specific Interleukin-22 Expression in Mice: Implications for Human Liver Disease Progression
  2. Park, O.; Wang, H.; Weng, H. L.; Feigenbaum, L.; Li, H.; Yin, S.; Ki, S. H.; Yoo, S. H.; Dooley, S.; Wang, F. S.; Young, H. A.; Gao, B.
  3. Hepatology. 2011, Jul; 54(1): 252-261.
  1. 4.   Twice-weekly pegylated interferon-alpha-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy
  2. Murphy, A. A.; Herrmann, E.; Osinusi, A. O.; Wu, L.; Sachau, W.; Lempicki, R. A.; Yang, J.; Chung, T. L.; Wood, B. J.; Haagmans, B. L.; Kottilil, S.; Polis, M. A.
  3. Aids. 2011, Jun; 25(9): 1179-1187.
  1. 5.   KIR Polymorphisms Modulate Peptide-Dependent Binding to an MHC Class I Ligand with a Bw6 Motif
  2. Colantonio, A. D.; Bimber, B. N.; Neidermyer, W. J.; Reeves, R. K.; Alter, G.; Altfeld, M.; Johnson, R. P.; Carrington, M.; O'Connor, D. H.; Evans, D. T.
  3. Plos Pathogens. 2011, Mar; 7(3): 13.
  1. 6.   HCV in Peripheral Blood Mononuclear Cells Are Predominantly Carried on the Surface of Cells in HIV/HCV Co-Infected Individuals
  2. Natarajan, V.; Kottilil, S.; Hazen, A.; Adelsberger, J.; Murphy, A. A.; Polis, M. A.; Kovacs, J. A.
  3. Journal of Medical Virology. 2010, Dec; 82(12): 2032-2037.
  1. 7.   Crystal Structure of Human Interferon-lambda 1 in Complex with Its High-Affinity Receptor Interferon-lambda R1
  2. Miknis, Z. J.; Magracheva, E.; Li, W.; Zdanov, A.; Kotenko, S. V.; Wlodawer, A.
  3. Journal of Molecular Biology. 2010, Dec; 404(4): 650-664.
  1. 8.   In the Absence of HCV Infection, Interferon Stimulated Gene Expression in Liver Is Not Associated With IL28B Genotype
  2. Shebl, F. M.; Maeder, D.; Shao, Y. W.; Prokunina-Olsson, L.; Schadt, E. E.; O'Brien, T. R.
  3. Gastroenterology. 2010, Oct; 139(4): 1422-1424.
  1. 9.   Elevated Systemic Levels of Inflammatory Cytokines in Older Women with Persistent Cervical Human Papillomavirus Infection
  2. Kemp, T. J.; Hildesheim, A.; Garcia-Pineres, A.; Williams, M. C.; Shearer, G. M.; Rodriguez, A. C.; Schiffman, M.; Burk, R.; Freer, E.; Bonilla, J.; Herrero, R.; Pinto, L. A.
  3. Cancer Epidemiology Biomarkers & Prevention. 2010, Aug; 19(8): 1954-1959.
  1. 10.   Safety, Tolerability, and Mechanisms of Antiretroviral Activity of Pegylated Interferon Alfa-2a in HIV-1-Monoinfected Participants: A Phase II Clinical Trial
  2. Asmuth, D. M.; Murphy, R. L.; Rosenkranz, S. L.; Lertora, J. J. L.; Kottilil, S.; Cramer, Y.; Chan, E. S.; Schooley, R. T.; Rinaldo, C. R.; Thielman, N.; Li, X. D.; Wahl, S. M.; Shore, J.; Janik, J.; Lempicki, R. A.; Simpson, Y.; Pollard, R. B.; Tea, A. C. T. G. A.
  3. Journal of Infectious Diseases. 2010, Jun 1; 201(11): 1686-1696.
  1. 11.   Clinical Use of Interferon-gamma
  2. Miller, C. H. T.; Maher, S. G.; Young, H. A.; Donnelly, R. P.
  3. Cytokine Therapies: Novel Approaches for Clinical Indications. 2009; 1182 : 69-79.
  1. 12.   High Specific Infectivity of Plasma Virus from the Pre-Ramp-Up and Ramp-Up Stages of Acute Simian Immunodeficiency Virus Infection
  2. Ma, Z. M.; Stone, M.; Piatak, M.; Schweighardt, B.; Haigwood, N. L.; Montefiori, D.; Lifson, J. D.; Busch, M. P.; Miller, C. J.
  3. Journal of Virology. 2009 83(7): 3288-3297.
  1. 13.   Protective HLA Class I Alleles That Restrict Acute-Phase CD8(+) T-Cell Responses Are Associated with Viral Escape Mutations Located in Highly Conserved Regions of Human Immunodeficiency Virus Type 1
  2. Wang, Y.; Li, B.; Carlson, J. M.; Streeck, H.; Gladden, A. D.; Goodman, R.; Schneidewind, A.; Power, K. A.; Toth, I.; Frahm, N.; Alter, G.; Brander, C.; Carrington, M.; Walker, B. D.; Altfeld, M.; Heckerman, D.; Allen, T. M.
  3. Journal of Virology. 2009 83(4): 1845-1855.
  1. 14.   Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: evidence for the processing of a viral-cellular double-stranded RNA hybrid
  2. Yeung, M. L.; Bennasser, Y.; Watashi, K.; Le, S. Y.; Houzet, L.; Jeang, K. T.
  3. Nucleic Acids Research. 2009 37(19): 6575-6586.
  1. 15.   Seroprevalence and risk factors for human herpesvirus 8 infection, rural egypt
  2. Mbulaiteye, S. M.; Pfeiffer, R. M.; Dolan, B.; Tsang, V.; Noh, J.; Mikhail, N.; Abdel-Hamid, M.; Hashem, M.; Whitby, D.; Strickl, G. T.; Goedert, J. J.
  3. Emerging Infectious Diseases. 2008 14(4): 586-591.
  1. 16.   Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients
  2. Neumann, A. U.; Polis, M. A.; Rozenberg, L.; Jackson, J. O.; Reitano, K. N.; McLaughlin, M.; Koratich, C.; Dewar, R. L.; Masur, H.; Haagmans, B. L.; Kottilil, S.
  3. Aids. 2007, Sep; 21(14): 1855-1865.
  1. 17.   Multiperson use of syringes among injection drug users in a needle exchange program: A gene-based molecular epidemiologic analysis
  2. Shrestha, S.; Smith, M. W.; Broman, K. W.; Farzadegan, H.; Vlahov, D.; Strathdee, S. A.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2006, Nov; 43(3): 335-343.
  1. 18.   Development of therapeutics for chronic HCV infection
  2. Huang, Z.; Murray, M. G.; Secrist, J. A.
  3. Antiviral Research. 2006, Sep; 71(2-3): 351-362.
  1. 19.   Role of DC-SIGN in the activation of dendritic cells by HPV-16 L1 virus-like particle vaccine
  2. Garcia-Pineres, A. J.; Hildesheim, A.; Trivett, M.; Williams, M.; Wu, L.; KewalRamani, V. N.; Pinto, L. A.
  3. European Journal of Immunology. 2006, Feb; 36(2): 437-445.
  1. 20.   Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearance
  2. Oleksyk, T. K.; Thio, C. L.; Truelove, A. L.; Goedert, J. J.; Donfield, S. M.; Kirk, G. D.; Thomas, D. L.; O'Brien, S. J.; Smith, M. W.
  3. Genes and Immunity. 2005, JUN; 6(4): 347-357.
  1. 21.   Binding of pregnancy-specific glycoprotein 17 to CD9 on macrophages induces secretion of IL-10, IL-6, PGE(2) and TGF-beta(1)
  2. Ha, C. T.; Waterhouse, R.; Wessells, J.; Wu, J. A.; Dveksler, G. S.
  3. Journal of Leukocyte Biology. 2005, JUN; 77(6): 948-957.
  1. 22.   The influence of HLA genotype on AIDS
  2. Carrington, M.; O'Brien, S. J.
  3. Annual Review of Medicine-Selected Topics in the Clinical Sciences. 2003 54: 535-551.
  1. 23.   The palm subdomain-based active site is internally permuted in viral RNA-dependent RNA polymerases of an ancient lineage
  2. Gorbalenya, A. E.; Pringle, F. M.; Zeddam, J. L.; Luke, B. T.; Cameron, C. E.; Kalmakoff, J.; Hanzlik, T. N.; Gordon, K. H. J.; Ward, V. K.
  3. Journal of Molecular Biology. 2002 324(1): 47-62.
  1. 24.   Local thermodynamic stability scores are well represented by a non-central student's t distribution
  2. Le, S. Y.; Liu, W. M.; Chen, J. H.; Maizel, J. V.
  3. Journal of Theoretical Biology. 2001 210(4): 411-423.
  1. 25.   A human RNA viral cysteine proteinase that depends upon a unique Zn2+-binding finger connecting the two domains of a papain-like fold
  2. Herold, J.; Siddell, S. G.; Gorbalenya, A. E.
  3. Journal of Biological Chemistry. 1999 274(21): 14918-14925.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel